Cipher Mining Announces June 2024 Operational Update
July 02, 2024 16:05 ET
|
Cipher Mining Inc.
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for June 2024. Key...
Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024
July 02, 2024 16:05 ET
|
Exponent, Inc.
MENLO PARK, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2024 financial results for the period ended...
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
July 02, 2024 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
Actelis Announces Closing of Exercise of Warrants for $2.25 Million Gross Proceeds
July 02, 2024 16:05 ET
|
Actelis Networks, Inc.
Actelis today announced the closing of its previously announced exercise of certain outstanding Series A-2 warrants.
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
July 02, 2024 16:05 ET
|
Gyre Therapeutics, Inc.
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
July 02, 2024 16:05 ET
|
BrightSpring Health Services, Inc.
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its second quarter...
Robinhood Markets, Inc. to Announce Second Quarter 2024 Results on August 7, 2024
July 02, 2024 16:05 ET
|
Robinhood Markets, Inc.
MENLO PARK, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its second quarter 2024 financial results on...
Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik
July 02, 2024 16:05 ET
|
Cartesian Therapeutics, Inc.
GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune...
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024 16:01 ET
|
Fate Therapeutics, Inc.
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent...
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
July 02, 2024 16:00 ET
|
Maravai LifeSciences Holdings LLC
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that...